Investigations using a larger number and more diverse types of human cancers should be conducted to elucidate the pathological relevance of the fluctuations in each acyl variant as well as their interaction with changes in oncogenes and tumor suppressor genes such as PIK3CA, K-, H-RAS, and PTEN. The gene discussed is PTEN; the disease is cancer.